Peer Review History
| Original SubmissionAugust 24, 2020 |
|---|
|
Dear Dr Catteruccia, Thank you very much for submitting your manuscript "A mating-induced reproductive gene promotes Anopheles tolerance to Plasmodium falciparum infection" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Kenneth D Vernick Associate Editor PLOS Pathogens Kirk Deitsch Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************** Reviewer Comments (if any, and for reference): Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: This study examined whether P. falciparum interferes with egg development in mated An. gambiae and An. stephensi females. The study builds up on earlier work from the same group (Werling et al. 2019) that found a positive correlation between egg numbers and parasite loads in virgin females. Although this result suggested a non-competitive interaction between P. falciparum and An. gambiae, it remained to be determined whether this finding extended to reproductively active, mated females and other Anopheles species. The fitness cost of malaria parasite infection in mosquitoes is a relevant and longstanding question in vector biology. Overall, I found this manuscript to be compelling and well written, and I think it will be of great interest to both vector biologists and a more general audience of evolutionary biologists. I have a few comments about the interpretation and discussion of the results, but with these relatively minor considerations taken into account, I would not hesitate to recommend this manuscript for publication. Reviewer #2: In this manuscript Marcenac et al. provide new information on reproduction and tolerance to Plasmodium infection. Through the use of reproduction/mating bioassays coupled with functional and infection experiments the authors provide convincing evidence that the MISO gene is involved in mosquito tolerance to Plasmodium infection, allowing it to maintain reproductive fitness. The manuscript adds much needed new knowledge to understand the effects of Plasmodium infection on mosquito reproductive fitness and provides some potential mechanistic evidence for the absence of detrimental effects of Pf infection in the most important Anopheline vectors. The manuscript is easy to read and well organized when presenting the data via graphs or during the discussion section. I commend the authors for providing alternative hypothesis, not shying away from writing other potential explanations of the observable data. ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: (No Response) Reviewer #2: I don't see any major experiment that needs to be conducted. The experiments appear solid. ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: 1) My most significant criticism is about the primary phenotype examined to measure the fitness cost of P. falciparum infection. The number of developed eggs within the ovaries after a single blood meal is only a partial measure of the mosquito’s reproductive output. Ideally, not only the total number of eggs laid across multiple gonotrophic cycles throughout a female’s lifetime (fecundity) should have been considered, but also the viability of these eggs (fertility) should have been assessed to more accurately estimate the overall fitness. I suggest the authors tone down their claims about fitness and the fitness cost of infection, and better contextualize their findings. For example, the statement that “P. falciparum infections do not affect the reproductive fitness” (line 197) should explicitly mention the caveat that the phenotype examined (number of developed eggs within the ovaries) did not fully encapsulate fitness. Following up on the above point, why were the females not allowed to lay their eggs in the experiments? Oocyst numbers could have been determined after oviposition to obtain paired fecundity and parasite load measurements. Interfering with the natural process and time frame of oviposition may have altered life-history and resource allocation trade-offs. The authors may also consider justifying/discussing this point. 2) Another aspect that may deserve to be discussed further relates to the concept of host tolerance. Tolerance is often represented as the negative slope of host fitness as a function of parasite burden. Individuals with a shallower slope are more tolerant because they maintain higher fitness at high parasite loads. In the present study, the relationship between the probability of egg development and the number of oocysts was negative in MISO-depleted individuals, consistent with a relatively lack of tolerance, however the same relationship had a positive slope in the control mosquitoes (Fig. 3D). Could this positive slope reflect the cost of resistance of individuals with low parasite numbers, if females who are able to clear the infection are less likely to produce eggs ? Or to the contrary, a positive effect of high parasite loads on the probability of egg development? In the same line, the previous work from this group (Werling et al. 2019) found a positive relationship between egg and parasite numbers in laboratory assays. Because this specific result was not confirmed in the field-based experiments of the present study (Fig. 3C), it would be interesting to discuss the potential reasons underlying this discrepancy. 3) The statistical analyses were performed according to very high standards, however it would have been useful to specify how the error distribution was chosen in the various models. Also, why were oocyst prevalence and intensity analyzed by separate GLMMs, whereas zero and non-zero egg counts were analyzed together? Reviewer #2: It would be good if the authors describe how many independent experiments were conducted and represented in each graph. Also, I am curious to know how the authors decided to employ Tukey HSD to do pairwise analysis. One of the assumptions for using Tukey HSD is that of equal sample sizes for each treatment; but on the graphs (in particular 2B) has vastly different sample sizes. Perhaps I am misunderstanding something here? ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Louis Lambrechts Reviewer #2: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods |
| Revision 1 |
|
Dear Dr Catteruccia, We are pleased to inform you that your manuscript 'A mating-induced reproductive gene promotes Anopheles tolerance to Plasmodium falciparum infection' has been provisionally accepted for publication in PLOS Pathogens. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Kenneth D Vernick Associate Editor PLOS Pathogens Kirk Deitsch Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************************************************** Reviewer Comments (if any, and for reference): |
| Formally Accepted |
|
Dear Dr Catteruccia, We are delighted to inform you that your manuscript, "A mating-induced reproductive gene promotes Anopheles tolerance to Plasmodium falciparum infection," has been formally accepted for publication in PLOS Pathogens. We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .